--- title: "12 Health Care Stocks Moving In Friday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/280789984.md" description: "In Friday's pre-market session, several health care stocks experienced notable movements. Pomdoctor (POM) shares surged 33% to $0.36, while OnKure Therapeutics (OKUR) rose 19.17% to $5.47. Other gainers included GlucoTrack (GCTK) up 17.42% to $1.28, Lantern Pharma (LTRN) up 12.44% to $2.35, and Rocket Pharmaceuticals (RCKT) up 11.3% to $5.22. Conversely, ENDRA Life Sciences (NDRA) fell 12.4% to $4.02, Universe Pharmaceuticals (UPC) dropped 10.26% to $2.1, and Acumen Pharmaceuticals (ABOS) declined 10.2% to $2.29. Quoin Pharmaceuticals (QNRX) and Zenas BioPharma (ZBIO) also saw declines following their Q4 earnings reports." datetime: "2026-03-27T12:05:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280789984.md) - [en](https://longbridge.com/en/news/280789984.md) - [zh-HK](https://longbridge.com/zh-HK/news/280789984.md) --- # 12 Health Care Stocks Moving In Friday's Pre-Market Session ### Gainers - **Pomdoctor** (NASDAQ:POM) shares rose 33.0% to $0.36 during Friday's pre-market session. The market value of their outstanding shares is at $32.2 million. - **OnKure Therapeutics** (NASDAQ:OKUR) shares increased by 19.17% to $5.47. The company's market cap stands at $62.7 million. - **GlucoTrack** (NASDAQ:GCTK) shares rose 17.42% to $1.28. - **Lantern Pharma** (NASDAQ:LTRN) stock moved upwards by 12.44% to $2.35. The market value of their outstanding shares is at $23.3 million. - **Rocket Pharmaceuticals** (NASDAQ:RCKT) shares increased by 11.3% to $5.22. The company's market cap stands at $509.1 million. - **ADMA Biologics** (NASDAQ:ADMA) shares increased by 10.73% to $9.18. The market value of their outstanding shares is at $1.9 billion. ### Losers - **ENDRA Life Sciences** (NASDAQ:NDRA) shares fell 12.4% to $4.02 during Friday's pre-market session. The company's market cap stands at $5.3 million. - **Universe Pharmaceuticals** (NASDAQ:UPC) shares fell 10.26% to $2.1. The market value of their outstanding shares is at $1.3 million. - **Acumen Pharmaceuticals** (NASDAQ:ABOS) stock declined by 10.2% to $2.29. The market value of their outstanding shares is at $154.4 million. As per the news, the Q4 earnings report came out yesterday. - **Quoin Pharmaceuticals** (NASDAQ:QNRX) shares decreased by 9.99% to $6.81. The market value of their outstanding shares is at $12.2 million. The company's, Q4 earnings came out yesterday. - **Zenas BioPharma** (NASDAQ:ZBIO) stock declined by 9.93% to $19.96. The company's market cap stands at $1.2 billion. - **Impact BioMedical** (AMEX:IBO) stock fell 9.3% to $0.51. The company's market cap stands at $60.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [RCKT.US](https://longbridge.com/en/quote/RCKT.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [NDRA.US](https://longbridge.com/en/quote/NDRA.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [QNRX.US](https://longbridge.com/en/quote/QNRX.US.md) - [POM.US](https://longbridge.com/en/quote/POM.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [LTRN.US](https://longbridge.com/en/quote/LTRN.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [ABOS.US](https://longbridge.com/en/quote/ABOS.US.md) - [OKUR.US](https://longbridge.com/en/quote/OKUR.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [UPC.US](https://longbridge.com/en/quote/UPC.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) ## Related News & Research - [POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results | POM Stock News](https://longbridge.com/en/news/286463818.md) - [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md) - [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md) - [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md) - [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)